A late-stage study has shown promising results for the effectiveness of fenfluramine in people with an ultra-rare form of epilepsy - CDKL5 deficiency disorder (CDD).

Campaigns Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online trolling, and from ...

It is always your choice as to whether you want to receive information from us. You may opt-out of our marketing communications by clicking the ‘unsubscribe’ link at the end of our marketing emails or ...

Sodium valproate is an epilepsy medication prescribed for all seizure types including absence, myoclonus and tonic clonic seizures. New regulations have been introduced by the Medicines and Healthcare ...

A new project in Australia is using AI to fast-track the time between diagnosis and seizure control, with the aim of improving outcomes for people with epilepsy. Advancements in technology are ...

As part of the reforms to the NHS, millions more patients will receive appointments, screening invitations and other important information directly via the NHS App as part of the digital-first upgrade ...

Epilepsy Society has welcomed new plans to boost clinical trials in the UK as part of the NHS 10-year health plan. The government has announced that millions of people will now be able to search for ...

A survey* carried out by the Epilepsy Society showed that 62 per cent of people with uncontrolled seizures experience an increase in their seizure activity during unusually hot weather. It is ...

As we continue to experience increasingly hot summers, researchers warn that commonly prescribed anti-seizure medications could be affected by the heat. And they are calling for further studies to ...

6-hour online course providing delegates with an understanding of epilepsy, how to manage different types of seizures and administer emergency medication. The course includes: an introduction to ...